News

All News

Luxium

SK Capital Partners and Edgewater Capital Partners Announce Agreement to Sell Luxium Solutions to Excelitas Technologies

Genetix

bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots

J&K Ingredients

J&K Ingredients Makes Strategic IP Acquisition from NuTek Natural Ingredients, Strengthening Technical Leadership in Clean-Label Solutions

Acquisitions

SK Capital has entered into exclusive negotiations to acquire LISI Group’s Medical division

Acquisitions

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

Uncategorized

Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer

Displaying 6 of 195 News Articles

×
×